Klotho Sciences is pioneering the global development of innovative Klotho-targeted therapeutics through its proprietary Klotho-targeted drug discovery
platform, identifying promising candidates for first-in-class treatments.

The correlation between declining Klotho protein levels and the progression of AD/CKD has been well established. As a result,restoring Klotho protein levels has become a novel
therapeutic goal for AD/CKD treatment. Small molecules are the optimal approach for fully restoring the pleiotropic functions of Klotho.